VECURONIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vecuronium Bromide, and when can generic versions of Vecuronium Bromide launch?
Vecuronium Bromide is a drug marketed by Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vecuronium Bromide
A generic version of VECURONIUM BROMIDE was approved as vecuronium bromide by MEITHEAL on August 25th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VECURONIUM BROMIDE?
- What are the global sales for VECURONIUM BROMIDE?
- What is Average Wholesale Price for VECURONIUM BROMIDE?
Summary for VECURONIUM BROMIDE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 12 |
| Patent Applications: | 1,721 |
| DailyMed Link: | VECURONIUM BROMIDE at DailyMed |
Recent Clinical Trials for VECURONIUM BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fudan University | Phase 4 |
| The Second Affiliated Hospital of Harbin Medical University | Phase 4 |
| Ningbo No. 1 Hospital | Phase 4 |
Pharmacology for VECURONIUM BROMIDE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for VECURONIUM BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for VECURONIUM BROMIDE
US Patents and Regulatory Information for VECURONIUM BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 206670-001 | Dec 20, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-001 | Dec 29, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 203725-001 | Jul 30, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390-002 | May 26, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 075164-001 | Oct 21, 1999 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 079001-001 | Jun 17, 2009 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
